Improved Diagnosis of Congenital Heart Disease by Magnetic Resonance Imaging Using Vasovist
Status:
Unknown status
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
Magnetic Resonance Imaging (MRI) is an effective and radiation free method of diagnosing
Congenital Heart Disease (CHD). MRI works by taking images of the anatomy and physiology.
These images also provide information on the hearts function and blood flow. The clarity of
these images is enhanced by the use of contrast agents (dyes). However these agents only stay
in the blood vessels for a short time and therefore limit the time in which the better
quality images can be obtained. This study aims to determine whether MRI using Vasovist (a
dye that stays in the vessels for a prolonged period of time) can improve the diagnosis of
Congenital Heart Disease (CHD) by allowing more areas to be imaged and the improved
assessment of various parameters (anatomy, volumes, flow) as well as vastly improving image
quality.